Amyloid beta-Peptides

"Amyloid beta-Peptides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Peptides generated from AMYLOID BETA-PEPTIDES PRECURSOR. An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). The peptide is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue.

Descriptor ID	D016229
MeSH Number(s)	D12.644.024 D12.776.049.407.249.500 D12.776.543.039.500
Concept/Terms	Amyloid beta-Peptides Amyloid beta-Peptides Amyloid beta Peptides beta-Peptides, Amyloid Alzheimer's ABP ABP, Alzheimer's Alzheimer ABP Alzheimers ABP Alzheimer's Amyloid Fibril Protein Amyloid AD-AP AD-AP, Amyloid Amyloid AD AP beta-Amyloid Protein Protein, beta-Amyloid beta Amyloid Protein Amyloid beta-Protein Amyloid beta Protein beta-Protein, Amyloid Amyloid beta-Proteins Amyloid beta Proteins beta-Proteins, Amyloid Amyloid Fibril Protein, Alzheimer's Amyloid Protein A4 Protein A4, Amyloid Alzheimer beta-Protein Alzheimer beta Protein beta-Protein, Alzheimer Amyloid beta-Peptide Amyloid beta Peptide beta-Peptide, Amyloid

Below are MeSH descriptors whose meaning is more general than "Amyloid beta-Peptides".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Peptides [D12.644]
Amyloid beta-Peptides [D12.644.024]
Proteins [D12.776]
Amyloid [D12.776.049]
Amyloidogenic Proteins [D12.776.049.407]
Amyloid beta-Protein Precursor [D12.776.049.407.249]
Amyloid beta-Peptides [D12.776.049.407.249.500]
Membrane Proteins [D12.776.543]
Amyloid beta-Protein Precursor [D12.776.543.039]
Amyloid beta-Peptides [D12.776.543.039.500]

Below are MeSH descriptors whose meaning is related to "Amyloid beta-Peptides".

Below are MeSH descriptors whose meaning is more specific than "Amyloid beta-Peptides".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Amyloid beta-Peptides" by people in this website by year, and whether "Amyloid beta-Peptides" was a major or minor topic of these publications.

Bar chart showing 289 publications over 26 distinct years, with a maximum of 29 publications in 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1998	1	0	1
2001	3	0	3
2002	3	1	4
2003	1	1	2
2005	6	1	7
2006	4	2	6
2007	3	3	6
2008	4	0	4
2009	5	7	12
2010	8	6	14
2011	9	3	12
2012	5	4	9
2013	3	3	6
2014	5	5	10
2015	7	2	9
2016	6	3	9
2017	5	4	9
2018	5	6	11
2019	12	10	22
2020	8	12	20
2021	2	11	13
2022	3	22	25
2023	2	19	21
2024	14	15	29
2025	7	10	17
2026	5	3	8

Below are the most recent publications written about "Amyloid beta-Peptides" by people in Profiles.

Saef B, Petersen KK, Volluz K, Li Y, Tosun D, Mila-Aloma M, Shaw LM, Zetterberg H, Dage JL, Rubel CE, Ferber K, Du-Cuny L, Coomaraswamy J, Baratta M, Mordashova Y, Saad ZS, Triana-Baltzer G, Ashton NJ, Meyers EA, Rosenbaugh EG, Sabandal JM, Bannon AW, Potter WZ, Schindler SE. Exploring longitudinal relationships among Alzheimer's disease biomarkers. Alzheimers Dement. 2026 Aug; 22(8):e71711.

View in: PubMed
Rosen-Lang Y, Vrillon A, Pasternak S, Blazhenets G, Soleimani-Meigooni DN, Rabinovici GD, Weiner MW, Hantke N, Silbert LC, Schwartz DL, Livny-Ezer A, Lesman-Segev O, Ganmore I, Ravona-Springer R, Yaffe K, Landau SM, Korecka M, Shaw LM, La Joie R, Gardner RC. Prior Traumatic Brain Injury and Alzheimer Disease Blood Biomarkers. JAMA Neurol. 2026 Aug 01; 83(8):759-768.

View in: PubMed
Veitch DP, Miller MJ, Kanoria S, Aisen PS, Beckett LA, Green RC, Harvey DJ, Jack CR, Jagust W, Lee EB, Nho K, Nosheny R, Okonkwo OC, Perrin RJ, Petersen RC, Mindt MR, Saykin AJ, Shaw LM, Toga AW, Tosun D, Landau SM, Weiner MW. Contributions of the Alzheimer's Disease Neuroimaging Initiative to advancing AD research: a targeted review of recent publications. Alzheimers Dement. 2026 Jun; 22(6):e71566.

View in: PubMed
Jiang X, Hoang TD, Shaw LM, Jacobs DR, Nasrallah IM, Bryan RN, Yaffe K. Alzheimer's disease neuropathology plasma biomarkers and cognition in midlife: a community-based cohort study. Lancet. 2026 May 30; 407(10544):2208-2216.

View in: PubMed
Timsina J, Jiang C, McCartney DL, Tao F, Dalmasso MC, Najar J, Anastasi F, Ohlei O, Puerta Fuentes R, Yang C, Bradley J, Western D, Ali M, Wang C, Yang C, Wu Y, Liu M, Budde J, Williams J, Mahoney R, Castillo Morales A, Hohman TJ, Dumitrescu L, Wang TC, Tesi N, Kern S, Waern M, Skoog I, van Harten A, Pijnenburg YAL, van der Flier WM, S?nchez-Juan P, Rodriguez-Rodriguez E, Kleineidam L, Peters O, Schneider A, K???kali F, Bellenguez C, Grenier-Boley B, Heikkinen S, de Rojas I, Rujescu D, Scherbaum N, Hausner L, D?zel E, Grimmer T, Wiltfang J, Vandenberghe R, Engelborghs S, Heilmann-Heimbach S, Schmid M, Tegos T, Scarmeas N, Dols-Icardo O, Moreno F, P?rez-Tur J, Bullido MJ, S?nchez-Valle R, ?lvarez V, Garc?a-Gonz?lez P, Mir P, Real LM, Pi?ol-Ripoll G, Garc?a-Alberca JM, Seelaar H, Ramakers I, Papma J, Hulsman M, Laske C, Teipel S, Priller J, Perneczky R, Buerger K, N?then MM, Lewczuk P, Kornhuber J, Hampel H, Giegling I, Goldhardt O, Diehl-Schmid J, Andrade V, Heneka MM, Fr?lich L, Vogelgsang J, Graff C, Thonberg H, Ullgren A, Papenberg G, Deleuze JF, Dufouil C, Wagner M, Jessen F, Holstege H, van Duijn C, Lebouvier T, Hannon O, Leinonen V, Soininen H, Herukka SK, Giedraitis V, L?wenmark M, Kilander L, Genius P, Rodr?guez B, Luckett ES, Navarro A, Cano A, Marqui? M, Blennow K, Zetterberg H, Lleo A, Boada M, Ruiz A, Lee VM, Van Deerlin VM, Deming Y, Johnson SC, Engelman CD, Pastor P, Alvarez I, Peskind ER, Heslegrave AJ, Saykin AJ, Nho K, Schindler SE, Morris JC, Holtzman DM, McDade E, Renton AE, Goate A, Ibanez L, Riemenschneider M, Albert MS, Laws SM, Porter T, O'Brien EK, Shaw LM, Tijms BM, Ingelsson M, Visser PJ, Hiltunen M, Sleegers K, Ritchie CW, Sims R, Belloy M, Lambert JC, Vilor-Tejedor N, Fern?ndez MV, Li QS, Nagle MW, Marioni RE, Ramirez A, Bertram L, van der Lee SJ, Cruchaga C. GWAS meta-analysis of cerebrospinal fluid Alzheimer's biomarkers reveals loci regulating lipids, brain volume and autophagy. Nat Commun. 2026 Apr 21; 17(1).

View in: PubMed
Robinson TL, Montenegro GDC, Fu JF, Pintucci EN, Properzi MJ, Penney DL, Davis R, Sperling RA, Johnson KA, Amariglio RE, Rentz DM. Digital maze test reveals cognitive performance patterns associated with amyloid-? and tau. Neuropsychology. 2026 Jul; 40(5):465-475.

View in: PubMed
Petersen KK, Mil?-Alom? M, Li Y, Du L, Xiong C, Tosun D, Saef B, Saad ZS, Du-Cuny L, Coomaraswamy J, Mordashova Y, Rubel CE, Meyers EA, Shaw LM, Dage JL, Ashton NJ, Zetterberg H, Ferber K, Triana-Baltzer G, Baratta M, Rosenbaugh EG, Cruchaga C, McDade E, Holtzman DM, Morris JC, Sabandal JM, Bateman RJ, Bannon AW, Potter WZ, Schindler SE. Predicting onset of symptomatic Alzheimer's disease with plasma p-tau217 clocks. Nat Med. 2026 Mar; 32(3):1085-1094.

View in: PubMed
C?novas R, Cox T, Dor? V, Bourgeat P, Fripp J, Feizpour A, Shishegar R, Fowler CJ, Laws SM, Porter T, Rainey-Smith S, Shaw LM, Bateman RJ, Li Y, Vitaliy O, Weiner MW, Morris JC, Benzinger TLS, Schindler SE, Nakamura A, Iwatsubo T, Ikeuchi T, Kato T, Maruff P, Sohrabi HR, Rowe CC, Martins RN, Masters CL, Doecke JD. When Does Alzheimer's Disease Start? Plasma A?42/40 Assays Show Steep Changes at A?-PET Centiloid 15, Mean Age of 66?Years. Ann Neurol. 2026 May; 99(5):1327-1342.

View in: PubMed
Zhang B, McEvoy LK, Nguyen S, Espeland MA, Rapp SR, Horvath S, Lu AT, LaCroix AZ, Nievergelt CM, Maihofer AX, Resnick SM, Mielke MM, Beckman K, Li D, Silver B, Manson JE, Ferrucci L, Shadyab AH. Epigenetic clocks and longitudinal plasma biomarkers of Alzheimer's disease. Alzheimers Dement. 2025 12; 21(12):e70983.

View in: PubMed
Ravichandran KA, Brosseron F, McManus RM, Ising C, G?rgen S, Schmidt SV, Santarelli F, Lee SY, Jung H, Chung WS, Kim CH, Ruiz Laza A, Ruiz de Almod?var C, Ramirez A, Latz E, Heneka MT. Enhancing Tyro3 signaling ameliorates IL-1? production through STAT1 in Alzheimer's disease models. J Leukoc Biol. 2025 Dec 01; 117(12).

View in: PubMed

People

Explore

Similar Concepts

Top Journals